Epstein-Barr Virus (EBV) Early Antigen (D) IgG Antibody Test in Dubai, UAE

Executive Summary & Core Metrics

Price: 1,800 AED (All-inclusive)
Turnaround Time: 14–21 days (specialized send-out)
Diagnostic Sensitivity: 99.9% via ISO 9001:2015 certified reference lab
Collection Method: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily)
Post-Test Support: Physician teleconsultation to review results and next steps
Insurance Verification: Direct confirmation via WhatsApp at +971 54 548 8731

Test Overview & Methodology

The Epstein-Barr Virus (EBV) Early Antigen (D) IgG antibody test is a quantitative serological assay that detects IgG antibodies against the diffuse early antigen complex of EBV. This marker is associated with active viral replication and is used to differentiate acute/recent infection from chronic active EBV, as well as to screen for EBV-related malignancies such as nasopharyngeal carcinoma. The test is performed using chemiluminescent immunoassay (CLIA) or enzyme-linked immunosorbent assay (ELISA) on a serum sample, providing high specificity for the EA-D antigen.

Feature	Our Test (Precision/Method/Speed)	Closest Alternative (Standard EBV Panel)
Target Analyte	Anti-EBV Early Antigen D IgG	VCA IgG/IgM, EBNA IgG only
Methodology	Chemiluminescent Immunoassay (CLIA) / ELISA – high specificity for EA-D	Basic immunoassay; may miss early antigen responses
Clinical Utility	Detects active viral replication; marker for chronic active EBV & nasopharyngeal carcinoma screening	Primarily for past/primary infection staging; limited for chronic conditions
Turnaround Time	2–3 weeks (send-out to specialized reference lab)	1–5 days (in-house)

Physician Insight & Safety Protocols

Dr. Ajay Singh | General Practitioner | DHA Registration ID: 36234132

“As a general practitioner, I see many patients with persistent fatigue, fever, and swollen glands. The EBV Early Antigen D IgG test provides crucial information when standard viral panels are inconclusive. A positive result indicates active viral replication, but it must always be interpreted alongside clinical history, physical examination, and other lab markers like VCA and EBNA. Never make decisions based on a single test result alone.”

Advisory: Medication and Preparation

Do not discontinue any prescribed medications, especially antiviral or immunosuppressive therapies, without consulting your doctor. This test does not require fasting or medication hold; however, always inform your healthcare provider about all supplements and drugs you are taking. A signed Test Send-Out Consent Form (Form 35) is mandatory before blood collection.

Exclusion Criteria & When to Seek Emergency Care

Exclusion: This test is not recommended for children under 5 years unless specifically ordered by a pediatric infectious disease specialist.
Emergency Red Flags: Go to the nearest emergency room immediately if you experience difficulty breathing due to severe sore throat, intense abdominal pain, jaundice (yellowing of skin/eyes), confusion, seizures, or any neurological symptoms. These may indicate complications such as splenic rupture or encephalitis.
Sample Requirements: A 2 mL serum sample (SST tube) is required. Hemolyzed, lipemic, or icteric samples may be rejected. Specimens must be refrigerated or frozen and transported via cold chain.

Patient FAQ & Clinical Guidance

1. What does a positive EBV Early Antigen D IgG result indicate?

A positive result suggests active EBV replication and is often seen in chronic active EBV infection or nasopharyngeal carcinoma. Clinical interpretation must integrate VCA IgG/IgM and EBNA-1 IgG patterns. Your physician will determine whether this represents primary infection, reactivation, or a malignancy-associated serology profile.

2. How should I prepare for this test?

No fasting is required. Simply sign the mandatory Test Send-Out Consent Form (Form 35) provided by our team before blood collection. A 2 mL serum sample will be drawn into an SST tube. Home collection is available daily from 8 AM to 11 PM via our VIP Mobile Phlebotomy service. Samples are kept refrigerated and shipped to the reference laboratory on scheduled batches.

3. Why does the test take 2–3 weeks and cost 1,800 AED?

This is a specialized send-out assay performed at an international reference laboratory to ensure high accuracy and compliance with ISO 9001:2015 standards. The price includes cold-chain logistics, advanced immunoassay technology (CLIA/ELISA), and a comprehensive clinical report. Insurance may cover part of the cost; verify your coverage via WhatsApp at +971 54 548 8731.

UAE Regulatory & Data Privacy Adherence

This service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical content is reviewed by licensed physicians with DHA credentials. Our laboratory holds ISO 9001:2015 certification (Certificate: INT/EGQ/2509DA/3139). Your data is handled with the highest security standards, and no third-party access is granted without your explicit consent.

Clinical & Logistical Metadata

Test Name	Epstein-Barr Virus (EBV) Early Antigen (D) IgG Antibody
Price (AED)	1,800 AED
Turnaround Time	14–21 days (2–3 weeks)
Sample Type / Matrix	Serum (peripheral whole blood, SST tube)
Methodology Used	Chemiluminescent Immunoassay (CLIA) / Enzyme-Linked Immunosorbent Assay (ELISA)
ICD-10-CM Code	B27.0 (Gammaherpesviral mononucleosis due to EBV)
LOINC Code	2385-4 (Epstein-Barr virus early antigen Ab.IgG [Units/volume] in Serum)
DHA Facility License & Laboratory Address	DHA License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE